Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2002
08/28/2002EP1234823A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
08/28/2002EP1233963A2 Novel sulfonyl oxazole amines
08/28/2002EP1233958A1 Inhibitors of histone deacetylase
08/28/2002EP1233828A2 Chiral catalysts for asymmetric acylation and related transformations
08/28/2002EP1233789A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids
08/28/2002EP0993445B1 New oxime sulfonates and the use thereof as latent sulfonic acids
08/28/2002EP0988300B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
08/28/2002EP0973731B1 Hydroxamic acid derivatives
08/28/2002EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease
08/28/2002CN1366521A Substituted 1-aza-2-imino heterocycles and their use as nicotinic acetylcholine receptors activators
08/28/2002CN1365973A New cycloheplene compound, its preparation method and medicine composition containing same
08/28/2002CN1365967A Amine derivative with K channel regulation function and its preparing process and application
08/28/2002CN1365966A Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application
08/28/2002CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
08/28/2002CN1089757C Process for producing aminonitropyridines
08/28/2002CN1089756C Nitration of pyridine-2,6-diamines
08/28/2002CN1089749C Pesticidal hydrazide derivatives
08/28/2002CN1089549C Process for preparing N-acetonylbenzamide
08/27/2002US6441246 Using dehydration agent
08/27/2002US6441233 Carbonylation, amidation; in presence of acylation catalyst
08/27/2002US6441193 Intermediates such as 1-(2-(4-(6-methoxy-3,4-dihydronaphtha-len-1-yl)phenoxy)ethyl)pyrrolidine and compounds such as cis-6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol, hydrobromide salt
08/27/2002US6441182 Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
08/27/2002US6441181 Compound and process for producing β-adrenergic receptor agonist
08/27/2002US6441177 (4-bromo-phenyl)-(4-(6-(cyclopropyl-methyl-amino)-hexyloxy)-2-fluoro -phenyl)-methanone; antimycotic and cholesterol lowering activity
08/27/2002US6441042 Hydroxamic acid derivatives as antibacterials
08/27/2002US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
08/27/2002US6441021 Type-iv collagenase inhibitors
08/27/2002US6441010 Bi-aromatic compounds linked via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing them
08/27/2002US6441009 Carboxyl pyridine derivatives chelate and inactivate the metals which can be carcinogenic or poisonous
08/27/2002US6441008 Benzamide derivatives as thrombin inhibitors
08/27/2002US6441007 Treating central nervous system disorders with pyridyloxylalkylamines and phenoxyalkylamines
08/27/2002US6441006 Pharmaceutical compositions and methods for use
08/27/2002US6441002 The potent and selective cyclooxygenase-2 (cox-2) inhibitor etoricoxib
08/27/2002US6440975 Amino acid derivatives, the preparation and use thereof as endothelin antagonists
08/27/2002US6440972 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
08/27/2002US6440618 Imaging element containing a blocked photographically useful compound
08/22/2002WO2002064644A1 Complexed compounds and use thereof for the polymerisation of olefins
08/22/2002WO2002064588A1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides
08/22/2002WO2002064585A1 Synthesis method and intermediates of pyridin-2-yl-methylamine
08/22/2002WO2002064576A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
08/22/2002WO2002064568A1 Pyridine matrix metalloproteinase inhibitors
08/22/2002WO2002064567A2 Substituted carboxamides as inhibitors of factor xa
08/22/2002WO2002064566A1 Oxime o-ether compounds and fungicides for agricultural and horticultural use
08/22/2002WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
08/22/2002WO2002064547A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/22/2002WO2002064094A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
08/22/2002WO2002064080A2 Matrix metalloproteinase inhibitors
08/22/2002WO2002040008A3 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists
08/22/2002WO2002032893A3 Piperidine compounds as anti-allergic
08/22/2002WO2002032869A3 Substituted heterocyclic compounds for treating multidrug resistance
08/22/2002WO2002032377A3 Estrogen receptor modulators
08/22/2002WO2002004412A3 Tyrosine derivatives as phosphatase inhibitors
08/22/2002US20020115868 Novel process for making 5-substituted pyrazoles
08/22/2002US20020115865 2-methoxyimino-2- (pyridinyloxymethyl) phenyl acetamides with polyether derivatives on the pyridine ring
08/22/2002US20020115864 Potentiators of glutamate receptor function
08/22/2002US20020115860 Compositions and methods for hydration of terminal alkynes
08/22/2002US20020115858 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
08/22/2002US20020115854 Thrombin or factor Xa inhibitors
08/22/2002US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects
08/22/2002US20020115715 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
08/22/2002US20020115659 Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance
08/22/2002US20020115653 Retinoic acid mimetic anilides
08/22/2002US20020115635 Modulation of GSK-3beta activity and its different uses
08/22/2002CA2437643A1 Matrix metalloproteinase inhibitors
08/22/2002CA2437118A1 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
08/22/2002CA2435376A1 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
08/22/2002CA2434982A1 Pyridine matrix metalloproteinase inhibitors
08/22/2002CA2426535A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
08/21/2002EP1233010A1 Method for production of organic fluorine compound
08/21/2002EP1232150A1 Urea derivatives as anti-inflammatory agents
08/21/2002EP1232145A1 Method for producing hydroxymethylpyridines
08/21/2002EP1231919A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
08/21/2002EP1231912A1 Injectable preparation for controlling fish live comprising benzoyl urea derivatives
08/21/2002EP1053224B1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
08/21/2002CN1365357A Trifluoromethyl pyri(mi) diene carboxamides
08/21/2002CN1365354A Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
08/21/2002CN1365347A Anthracene derivatives and organic electroleuminescents device made by using the same
08/21/2002CN1364847A Metal ligand compound, luminous device and display device
08/21/2002CN1089437C Neutral molecular detection method and device including using new compound and painting materials
08/21/2002CN1089338C Pyridine derivatives as fungicides
08/20/2002US6437184 Insecticides, acaricides
08/20/2002US6437178 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid
08/20/2002US6437177 α-hydroxy, -amino, and halo derivatives of β-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors
08/20/2002US6437140 Process for preparing ethyl 3-(2,5,6-trihalopyridin-3-yl)-3-oxopropionate from 2,5,6-trihalo-3-cyanopyridine
08/20/2002US6437139 Omeprazole, lansoprazole and pantoprazole intermediates; free radical reaction with ethyl pyruvate to functionalize the 2-position
08/20/2002US6437130 For use in dye sensitizing type solar battery
08/20/2002US6437129 Armoatic or heteroarmoatic compound containing substituted amides or thioamides
08/20/2002US6437122 Method for producing a heterocyclic nitrile
08/20/2002US6436998 Administering amides having improved kinetics and reduced side effects; drug abuse, drug dependence
08/20/2002US6436973 Leukotriene enzyme inhibitors, administered as antiarthritic and antiinflammatory agents; prophylaxis of psoriasis and liver disorders
08/20/2002US6436972 Pyridones and their use as modulators of serine hydrolase enzymes
08/20/2002US6436969 Dialysis solutions and methods
08/20/2002US6436951 Camptothecin tetracyclic analogues, preparation, method, applications as medicines and pharmaceutical compositions containing them
08/20/2002US6436925 Better able to cross membranes; inhibitors of cysteine proteases like calpain i and ii and cathepsin b and l, can thus be used to control diseases associated with an elevated activity of calpain enzymes or cathepsin enzymes
08/20/2002US6436152 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/20/2002CA2216129C Lactam-containing hydroxamic acids
08/20/2002CA2208878C Production of benzaldehyde compounds